Comparison of [⁶⁸Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [¹⁸F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy

Investigators compared the performance of fibroblast activation protein inhibitor (FAPI) [68Ga]Ga-DOTA-FAPI-04, and conventional [18F]FDG PET/CT in patients with recurrent or metastatic solitary fibrous tumor.